Insider Trading Summary for Mersana Therapeutics, Inc. (MRSN): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
12-Jun-23 5:25 PM View:	08-Jun-23 Grant 0	Hack Andrew A. F. Director		Mersana Therapeutics, Inc. - MRSN	0% 8.66M to 8.68M	0	0	--	--	Show Txns Hide Txns

12-Jun-23 4:17 PM View:	08-Jun-23 Grant 0	Hege Kristen Director		Mersana Therapeutics, Inc. - MRSN	100% 0 to 14.47K	0	0	--	--	Show Txns Hide Txns

12-Jun-23 4:14 PM View:	08-Jun-23 Grant 0	Alleva Lawrence M Director		Mersana Therapeutics, Inc. - MRSN	682% 2.12K to 16.59K	0	0	--	--	Show Txns Hide Txns

04-Jan-24 4:11 PM View:	02-Jan-24 Grant 0	Dere Willard H Director		Mersana Therapeutics, Inc. - MRSN	1061% 3.38K to 39.18K	0	0	--	--	Show Txns Hide Txns

04-Jan-24 4:11 PM View:	02-Jan-24 Grant 0	Mott David M Director		Mersana Therapeutics, Inc. - MRSN	8% 553.06K to 598.29K	0	0	--	--	Show Txns Hide Txns

12-Jun-23 4:19 PM View:	08-Jun-23 Grant 0	Diaz Allene M. Director		Mersana Therapeutics, Inc. - MRSN	100% 0 to 14.47K	0	0	--	--	Show Txns Hide Txns

17-Jan-24 5:18 PM View:	16-Jan-24 Planned Option Sale ($11.87K)	Carvajal Alejandra SVP, Chief Legal Officer		Mersana Therapeutics, Inc. - MRSN	149% 11.02K to 27.4K	0	0	--	--	Show Txns Hide Txns

17-Jan-24 5:21 PM View:	16-Jan-24 Planned Option Sale ($9.10K)	Misra Tushar SVP, Chief Manuf. Officer		Mersana Therapeutics, Inc. - MRSN	151% 7.17K to 17.97K	0	0	--	--	Show Txns Hide Txns

17-Jan-24 5:20 PM View:	16-Jan-24 Planned Option Sale ($13.62K)	Mandelia Ashish VP, Chief Accounting Officer		Mersana Therapeutics, Inc. - MRSN	50% 15.57K to 23.33K	0	0	--	--	Show Txns Hide Txns

17-Jan-24 5:16 PM View:	16-Jan-24 Planned Option Sale ($9.30K)	Bala Mohan SVP, Chief Development Officer		Mersana Therapeutics, Inc. - MRSN	220% 4.39K to 14.05K	0	0	--	--	Show Txns Hide Txns

12-Jun-23 4:16 PM View:	08-Jun-23 Grant 0	Huber Martin H. Jr. President, CEO Director		Mersana Therapeutics, Inc. - MRSN	100% 0 to 14.47K	0	0	--	--	Show Txns Hide Txns

17-Jan-24 5:21 PM View:	16-Jan-24 Planned Option Sale ($79.67K)	Protopapas Anna Director		Mersana Therapeutics, Inc. - MRSN	20% 363.46K to 437.66K	0	0	--	--	Show Txns Hide Txns

17-Jan-24 5:18 PM View:	16-Jan-24 Planned Option Sale ($25.28K)	Deschuytner Brian SVP, COO & CFO		Mersana Therapeutics, Inc. - MRSN	46% 37.38K to 54.51K	0	0	--	--	Show Txns Hide Txns

17-Jan-24 5:19 PM View:	16-Jan-24 Planned Option Sale ($28.21K)	Lowinger Timothy B SVP, Chief Sci.&Tech. Officer		Mersana Therapeutics, Inc. - MRSN	11% 180.36K to 199.33K	0	0	--	--	Show Txns Hide Txns

Mersana Therapeutics, Inc. (MRSN)

Last Year

20-Apr-23 -- 19-Apr-24

Company Sentiment

Other

Other

Two Year Chart

20-Apr-22 -- 19-Apr-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--